LB
LAV Biosciences Fund V, L.P. disclosed a 11.1% stake in ADRX
LAV Biosciences Fund V, L.P. reported owning 11.1% of ADARx Pharmaceuticals, Inc. (ADRX) (11,858,655 shares) in a Schedule 13G filed Oct 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 16, 2026
- Source
- Schedule 13G